Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01571596 · ClinicalTrials.gov registry record · Phase 1

An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia

A Phase 1 study of X-linked Hypophosphatemia, sponsored by Kyowa Kirin Co..

Completed
Registry status
Phase 1
Development phase
23
Enrollment target
6
Study locations

NCT01571596 is a Phase 1 study of X-linked Hypophosphatemia that has completed, run by Kyowa Kirin Co.. The registered enrollment target is 23 participants, below the 170-participant average among 5 other X-linked Hypophosphatemia trials with a reported enrollment target (86% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01571596, a Phase 1 study of X-linked Hypophosphatemia, has completed, sponsored by Kyowa Kirin Co..

COMPLETED
Registry status
Phase 1
Development phase
23 participants
Enrollment target
6
Study locations

Study Summary

The primary purpose of this study is to assess the safety and efficacy of repeated subcutaneous (SC) injections of KRN23 in adult subjects with X-Linked Hypophosphatemia (XLH).

Conditions Studied

X-linked Hypophosphatemia

Interventions

  • DRUG KRN23

Study Locations (6)

California

  • University of California San Francisco - San Francisco

Connecticut

  • Yale University School of Medicine - New Haven

Indiana

  • Clinical Research Center, Indiana University School of Medicine - Indianapolis

North Carolina

  • Duke Clinical Research Unit - Durham

Texas

  • University of Texas Health Science Center at Houston - Houston

Quebec

  • Shriners Hospital for Children - Canada - Montreal

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2012-02
Est. Completion 2014-06
Phase Phase 1

Sponsor

Kyowa Kirin Co.

25 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01571596

The ClinicalTrials.gov registry entry for NCT01571596 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 5 other X-linked Hypophosphatemia trials with a reported enrollment target (86% lower). The listed sponsor is Kyowa Kirin Co., which has 25 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with X-linked Hypophosphatemia appearing as the primary indexed condition, and to 1 intervention - of which KRN23 is the first listed.

NCT01571596 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Connecticut, Indiana.

Frequently Asked Questions

What is clinical trial NCT01571596 about?

NCT01571596 is a clinical study titled "An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia". The primary purpose of this study is to assess the safety and efficacy of repeated subcutaneous (SC) injections of KRN23 in adult subjects with X-Linked Hypophosphatemia (XLH).

What is the current status of trial NCT01571596?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2012-02. Estimated completion is 2014-06.

What conditions does trial NCT01571596 study?

This clinical trial studies the following conditions: X-linked Hypophosphatemia.

What interventions are being tested in trial NCT01571596?

The interventions under investigation include: KRN23 (DRUG).

Who is sponsoring clinical trial NCT01571596?

This trial is sponsored by Kyowa Kirin Co., which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01571596 being conducted?

This trial has 6 study locations across California, Connecticut, Indiana, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for X-linked Hypophosphatemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

X-linked Hypophosphatemia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.